Ara Chackerian’s insight on healthcare startups

Ara Chackerian is currently the managing director of ASC Capital Holdings. He is an entrepreneur who is a devoted philanthropist. He was born in 1969. Ara is as also a co-founder of several companies which include BMC Diagnostics, PipelineRx, and TMS Health Solutions. Ara has an experience at executive level in all companies he has co-founded. Regarding his education background, Ara studied at the Florida state university where he graduated with B.S in marketing.

Ara Chackerian has diversified his career so much although less achievement is evident in his professional life. Nevertheless, one of the most remarkable position he has ever held is a managing partner of ASC Capital Holdings. Besides being an entrepreneur, Ara plays a humanitarian role with the aim of giving back to the community. He launched a mentoring program known as Nor Luyce to support orphans. Since the inception of the mentoring programme, Ara is the principal funder as well as the board member. Also, he has funded and launched many charitable organizations to support youths. Visit for more details.



Beyond his formal qualifications, Ara Chackerian is an innovator who wants to elevate the health care status. In the recent past, he has ventured into the medical field and has been scrutinizing the effects of innovation in the therapeutic area. He identified that successful healthcare ventures are subject to innovative entrepreneurs.


Statistically, in 2017 approximately 79 healthcare startups funding amounted to $703 million in New York City. However, most of the companies had negative cash flow, therefore; they could not declare their IPO. The statistical data raised concern, and many predicted that most healthcare companies are likely to collapse this year. However, Ara Chackerian among other entrepreneurs believes that experience hitches in their early years. Some of the hiccups include delays in IPO etc. In addition to the stated, healthcare startups will benefit experimental data that help them identify threats. Check out to know more.



Ara Chackerian believes that at the moment investors should not focus on profit concerning healthcare startups of today; nevertheless, they should focus on tomorrow’s outcome. He further identifies that any business worth risk taking.



Read more: